期刊文献+

甲状腺微小乳头状癌107例术中冷冻切片诊断分析 被引量:2

An Analysis on Diagnosis of Intraoperative Frozen Section in 107 Cases with Thyroid Papillary Microcarcinoma
原文传递
导出
摘要 [目的]探讨甲状腺微小乳头状癌(papillary thyroid microcarcinoma,PTMC)术中冷冻切片病理诊断的要点,分析造成术中冷冻切片误诊、漏诊的原因。[方法]回顾性分析107例PTMC患者的病理学特征、冷冻切片和石蜡切片结果以及免疫组化结果。[结果]术中冷冻切片确诊97例,延迟诊断4例,误诊4例,漏诊2例。冷冻切片易出现毛玻璃样核及核内包涵体等人工假象。其中81例PTMC石蜡切片免疫组化法CK19、Galectin-3、TPO阳性率分别为93.8%、88.9%、13.6%。[结论]核增大、核轮廓不规则、核重叠、核沟是冷冻切片诊断PTMC的重要核参数改变,需结合组织结构异型性明确诊断。仔细剖检、强化取材及严格掌握诊断标准是避免误诊和漏诊,提高PTMC检出率的关键。
出处 《肿瘤学杂志》 CAS 2013年第6期502-503,共2页 Journal of Chinese Oncology
  • 相关文献

参考文献2

二级参考文献27

  • 1柳文仪.甲状腺超声诊断现状[J].中国超声医学杂志,1995,11(4):272-273. 被引量:78
  • 2徐雅男,王家东.甲状腺乳头状微小癌淋巴结转移相关因素分析[J].临床耳鼻咽喉头颈外科杂志,2007,21(15):679-682. 被引量:19
  • 3Wong Z,Muthu C,Craik J,et al.Role of intraoperative frozen section in the management of thyroid nodules [J].ANZ J Surg,2004,74(12) : 1052-1055.
  • 4De Lellis RA,Lloyd RV,Heitz PU.World Health Organization Classification of Tumours:Pathology and Genetics of Tumours of the Endocrine Organs [M].3rd edn.Lyon:IARC Press,2004.58.
  • 5LiVoLsi VA.Surgieal Pathology of the Thyroid[M].W.B.Sannders company, 1990.131.
  • 6Fletcher CDM.Diagnostic histopathology of tumors[M].2nded. Churchill Livingstone, London, 2000.959.
  • 7Hofman V,Lassalle S,Bonnetaud C,et al.Thyroid tumours of uncertain malignant potential:frequency and diagnostic reproducibility[J].Virchows Arch, 2009,455 ( 1 ) : 21-33.
  • 8Chan JK.Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma [J].Am J Clin Pathol, 2002,117 ( 1 ) : 16-18.
  • 9Renshaw AA,Gould EW.Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma[J].Am J Clin Pathol,2002,117 ( 1 ) : 19-21.
  • 10Papotti M,Rodriguez J,De Pompa R,et al.Galectin-3 and HBME-1 expression in well-differentiated thyroid tumours with follicular architecture of uncertain malignant potential [J].Mod Patho1,2005,18(4) :541-546.

共引文献27

同被引文献23

  • 1Nikiforova MN, Caudill CM, Biddinger P, et al. Prevalence of RET/ PTC rearrangements in Hashimoto' s thyroiditis and papillary thyroid- carcinomas [ J ]. Int J Surg Patho1,2002,10 ( 1 ) : 15 -22. DOI : 10.1177/106689690201000104.
  • 2Coli A, Bigotti G, Zucchetti F, et al. Galectin-3, a marker of we/l-dif- ferentiated thyroid carcinoma, is expressed in thyroid nodules with cy- tological atypia[ J ]. Histopathology ,2002,40 ( 1 ) :80-87. DOI : 10. 1046/j. 1365-2559. 2002. 01304. x.
  • 3Zhu H, Peng YG, Ma SG, et al. TPO gene mutations associated with thyroid carcinoma: Case report and literature review [ J ]. Cancer Bio- mark,2015,15(6) :909-913. DOI: 10.3233/CBM-150522.
  • 4Ito Y,Uruno T,Nakano K. An obsercation trial without surgical treat- ment in patients with papillary microcareinoma of the thyroid [ J ] Thyroid ,2003,13 (4) :381-387.
  • 5Macak J, Rydlova M, Horacek J, et al. Simultaneous occurrence of pa- pillary carcinoma, oncocytic carcinoma and malignant lymphoma of the thyroid gland in a female patient with Hashimoto' s disease[ J]. Cesk Patol,2001,37( 1 ) :18-22.
  • 6Saggiorato E, Aversa S, Deandreis D, et al. Galectin-3 : presurgical marker of thyroid follicular epithelial cell-derived carcinomas [ J ]. J Endocrinol Invest,2004,27 (4) :311-317. DOI : 10. 1007/BF03351054.
  • 7Xing M. BRAF mutation in papillary thyroid cancer: pathogenicrole. molecular bases, and clinical implications [ J ]. Endocrine Reviews, 2007,28 (7) :742-762. DOI : http ://dx. doi. org/10. 1210/er. 2007-0007.
  • 8Nair M, Kapila K, Karak AK, et al. Papillary carcinoma of the thyroid and its variants: a cytohistological correlation [ J ]. Dia Cytopathol, 2001,24(3) :167-173. DOI:10. 1002::1097-0339 ( 200103 ) 24 : 3 < 167 : AID-DC1035 > 3. O. CO ;2-3.
  • 9高明.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床,2012,29(17):1249-1272. 被引量:761
  • 10林茂华,毛瑛玉,李婷,苏谦,郑建瑞.CK19、CyclinD1、HBME-1、34βE12、TPO、galectin-3在甲状腺乳头状癌组织中的表达及意义[J].实用癌症杂志,2013,28(6):617-619. 被引量:16

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部